Radicava® Oral Suspension Approved In Switzerland For The Treatment Of Als
11/05/2023 03:59
Mitsubishi Chemical Group Corp 4188.T :
* MITSUBISHI CHEMICAL GROUP - RADICAVA® ORAL SUSPENSION
APPROVED
IN SWITZERLAND FOR THE TREATMENT OF ALS
Source text for Eikon: ID:
Further company coverage: 4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)